SCHEDULE 13G/A: Anson Funds Group Discloses 5.4% Stake in Applied DNA Sciences Inc.

Anson Funds Management LP and its affiliated entities have disclosed a beneficial ownership of 5.4% in Applied DNA Sciences Inc., totaling 3,142,032 shares of common stock.

Summary

• Anson Funds Management LP, Anson Management GP LLC, Mr. Tony Moore, Anson Advisors Inc., Mr. Amin Nathoo, and Mr. Moez Kassam collectively reported beneficial ownership of 3,142,032 shares of Common Stock in Applied DNA Sciences Inc.
• This aggregate amount represents 5.4% of the outstanding shares of Common Stock of Applied DNA Sciences Inc.
• The percentage is calculated based on 55,188,523 shares of Common Stock issued and outstanding as of February 13, 2025, plus 2,931,978 shares receivable upon exercise of warrants held by the reporting group, totaling 58,120,501 shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• The disclosure of a significant 5.4% stake by a group of investment entities, Anson Funds, may signal confidence in Applied DNA Sciences Inc. from institutional investors.

Risks

• The filing itself does not detail specific risks to Applied DNA Sciences Inc.; it is a disclosure of beneficial ownership.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a standard disclosure of a significant ownership stake by an institutional investor group, common in the financial industry for transparency regarding large equity positions in publicly traded companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake provides transparency regarding the company's ownership structure and may be viewed as a positive signal of investor interest.

Key Dates

Keywords

Applied DNA Sciences Inc., Anson Funds Management LP, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Equity Stake